Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.

Autor: Baiza-Durán L; 1 Clinical Research Department , Laboratorios Sophia, SA de CV, Zapopan, México ., Olvera-Montaño O; 1 Clinical Research Department , Laboratorios Sophia, SA de CV, Zapopan, México ., Mercado-Sesma AR; 1 Clinical Research Department , Laboratorios Sophia, SA de CV, Zapopan, México .; 2 Department of Health-Disease Sciences, University Center of Tonala, University of Guadalajara , Guadalajara, Mexico ., Oregon-Miranda AA; 1 Clinical Research Department , Laboratorios Sophia, SA de CV, Zapopan, México ., Lizárraga-Corona A, Ochoa-Tabares JC, Pérez-Balbuena AL, Montoya-Sánchez IM, Saucedo-Rodríguez LR, Mora-González A, Gómez-Bastar PA, Villanueva-Najera MA, Sandoval-Delgadillo LI, González-Lomelí M, Páez-Garza JH, Orozco-Carroll M, Casillas-Magallanes M

Publikováno v: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 2018 Apr; Vol. 34 (3), pp. 250-255. Date of Electronic Publication: 2018 Jan 11.